Young David (CIK 0001378166)

Latest company ownership

PCSA - Processa Pharmaceuticals, Inc.

Role: Pres. Research & Development

Shares held

333,000

Last filed at

Oct 3, 2025

Confidence Score

49.5

2025Q4

Confidence Score History

2021Q2 2025Q4

Recent buy/sell transactions

Exec date	Filing date	Company	Role	Signal	Confidence	Shares	% of shares	Under plan?	Amount (USD)
Apr 1, 2025	Apr 11, 2025	Processa Pharmaceuticals, Inc.	Pres. Research & Development	Sell	27.5	-5,345	-1.89%	✗	$2.2K
Jan 27, 2025	Jan 29, 2025	Processa Pharmaceuticals, Inc.	Pres. Research & Development	Buy	95.0	+124,500	88.16%	✗	$99.3K
Apr 5, 2024	Aug 2, 2024	Processa Pharmaceuticals, Inc.	Pres. Research & Development	Sell	45.0	-800	-0.36%	✗	$1.9K
Jan 1, 2024	Apr 12, 2024	Processa Pharmaceuticals, Inc.	Pres. Research & Development	Sell	45.0	-518	-0.37%	✗	$1.4K
Feb 7, 2024	Feb 8, 2024	Processa Pharmaceuticals, Inc.	Pres. Research & Development	Buy	95.0	+21,000	17.69%	✗	$51.5K
Feb 6, 2024	Feb 7, 2024	Processa Pharmaceuticals, Inc.	Pres. Research & Development	Buy	95.0	+20,000	20.26%	✗	$50.5K
Jun 12, 2023	Jun 12, 2023	Processa Pharmaceuticals, Inc.	CEO	Buy	78.8	+40,000	2.44%	✗	$32K
Apr 14, 2023	Apr 14, 2023	Processa Pharmaceuticals, Inc.	CEO	Buy	78.8	+20,000	1.24%	✗	$11K
Apr 11, 2023	Apr 13, 2023	Processa Pharmaceuticals, Inc.	CEO	Buy	83.8	+60,000	3.85%	✗	$29K
Aug 5, 2022	Aug 9, 2022	Processa Pharmaceuticals, Inc.	CEO	Sell	52.5	-2,531	-0.15%	✗	$8K
Jun 23, 2021	Jun 23, 2021	Processa Pharmaceuticals, Inc.	CEO	Buy	72.5	+10,000	0.61%	✗	$76.7K